NEOVACS SA |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 EUR | -.--% |
|
-.--% | -.--% |
| Jun. 17 | Neovacs: collaboration agreement with CNRS | CF |
| Jun. 10 | Neovacs: presents results from vaccine candidates | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 58.24K | - | - | - | - | - | |
| 47.96B | - | |||||
| 41.47B | ||||||
| 42.45B | ||||||
| 31.6B | - | |||||
| 28.63B |
